Rangers Notes: Ragans, Odor, Mazara, Miller

The Rangers received yet even more terrible news on the prospect front Tuesday, as 2016 first-rounder Cole Ragans will undergo the second Tommy John surgery of his young career, per a team announcement. Ragans underwent Tommy John surgery last March but re-tore the ligament in his right elbow and will now miss a second season of development. The Rangers have already lost 2018 second-round pick Owen White and 2018 fourth-rounder Mason Englert to Tommy John surgery this season, thus wiping out the 2019 campaigns for three intriguing young prospects within the team’s minor league ranks. Ragans ranked as the team’s No. 10 overall prospect, per MLB.com, while White checked in at No. 12 and Englert sat at No. 23.

Some more news and notes out of Arlington…

• Evan Grant of the Dallas Morning News examines the struggles of both Rougned Odor and Nomar Mazara thus far in 2019. It’s been a catastrophic season for Odor, who entered play today with an almost unfathomable .137/.212/.253 batting line through 105 plate appearances. Mazara, meanwhile, is in a substantial funk that has dropped his overall line to .227/.287/.417 through yesterday’s game. Odor’s struggles have gotten to the point where an optional assignment almost has to be considered as a means of getting him back on track. He’s signed through the 2022 season but has yet to consistently produce at the big league level. He had a similar run of poor results in 2018 before snapping out of his slump and catching fire for much of the summer, and some work in the minors could help to clear his head and point him in that direction. Mazara likely has a longer leash given his more consistent track record and the need to evaluate him heading into his next arbitration raise. Even if the organization decides it best to shop Mazara this winter, demoting him would tank his trade value, so it seems best to allow him to continue trying to sort things out at the MLB level. It’s worth noting, of course, that as of this writing both Mazara and Odor have a pair of hits in tonight’s game.
• Shelby Miller’s hold on a spot in the rotation would appear to be tenuous, at best. Jeff Wilson of the Fort Worth Star-Telegram wrote yesterday that the organization’s plan was to keep Miller in the rotation but cap him at 70 pitches per start, but he wasn’t even able to last that long in tonight’s outing against the Royals. Kansas City jumped all over Miller on Tuesday, clobbering him for eight runs on seven hits and two walks with one strikeout in just 1 2/3 innings. Grant tweeted shortly thereafter that Miller seemed likely to be moved to the bullpen in favor of the younger Ariel Jurado, who has a 3.57 ERA through 22 2/3 innings in Triple-A and has fired off 9 2/3 scoreless innings out of the big league bullpen. Texas signed the 28-year-old Miller to a one-year deal this offseason in hopes that he could rebuild some stock and perhaps turn himself into a trade chip, but he’s allowed 31 earned runs in 29 1/3 innings with more walks allowed (23) than strikeouts recorded (20).